Since obesity is associated with a cluster of metabolic complications including liver disorders [24,25,26], and both organ-specific Napepld knockout mouse models previously investigated were prone to develop obesity-associated steatosis, we next wondered what would be the role of NAPE-PLD in the liver. This evidence concerns the gene NAPEPLD and obesity disorder.